Published animal studies using BPC-157, including those extending across multiple weeks of daily administration, have not documented tumor formation or accelerated malignant growth as an observed outcome
Organ Protection : BPC-157 reduces oxidative stress and inflammatory markers in liver, kidney, and cardiac tissue following toxic exposure
A function membership is only a dollar a day, $365 a year
Journal of Physiology and Pharmacology - duodenocolic fistula healing by pentadecapeptide bpc 157 in rats: Discusses leaky gut, tight junctions, and NO-system interaction
Ipamorelin A selective growth hormone secretagogue with a favorable side effect profile
The stable gastric pentadecapeptide BPC 157, an original cytoprotective antiulcer peptide that is used in ulcerative colitis and recently in a multiple sclerosis trial and that has an LD1 that has not been achieved [111], is known to have pleiotropic beneficial effects [111] and to interact with several molecular pathways [2, 2732]
